Eli Lilly Expands Partnership with Insilico Medicine to Advance AI-Driven Drug Discovery
A major breakthrough in pharmaceutical innovation has emerged as Eli Lilly deepens its collaboration with Insilico Medicine, in a deal valued at up to $2.75 billion. This expanded partnership underscores...
Read moreDetails